Skip to content

Ticagrelor Related Compound 47

Ticagrelor Related Compound 47

Product Description
CAT No.
ALN-T023054
CAS No.
1445580-43-7
Mol. F.
C14H21N5O5S
Mol. Wt.
371.4
Stock
Please Inquire
RFQ
Chemical Name : (1S,2S,3R,5R)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Smiles : OCCO[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(N=C(SCCC)N=C3O)=C3N=N2)C1
Inchi : InChI=1S/C28H42ClN9O8S2/c1-3-9-47-27-32-23(29)17(24(33-27)30-13-11-15(45-7-5-39)21(43)19(13)41)31-25-18-26(35-28(34-25)48-10-4-2)38(37-36-18)14-12-16(46-8-6-40)22(44)20(14)42/h13-16,19-22,39-44H,3-12H2,1-2H3,(H,30,32,33)(H,31,34,35)/t13-,14+,15-,16-,19-,20-,21+,22+/m0/s1

Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method

By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.nFrom World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.

Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies

By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav – From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724

Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)

By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara – From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42

Request For Quotation

Related Products